Metabolomics studies in Gastrointestinal cancer: a systematic review.
Introduction: This systemic review provides an overview of metabolic perturbations and possible mechanisms in gastrointestinal cancer. The authors discuss emerging challenges of technical and clinical application.Areas covered: In this systemic review, the authors summarized the current available results of metabolomic biomarkers linked to GI cancer, and discussed the altered metabolism pathways including carbohydrate metabolism, amino acid metabolism, lipids and nucleotide metabolism. Furthermore, future efforts need to adhere to normalize analysis procedures, validate with the larger cohort and utilize multiple-omics technologies. The authors conducted systematic literature research on biomarkers in non-invasive (urine, stool) or minimally invasive (blood) collectable bio-samples that might be promising for early detection of GI. The search was conducted in PubMed with the following search terms (biomarker, gastrointestinal cancer, Colorectal cancer, Esophageal cancer) from 2013 to 2019.Expert opinion: This systemic review summarized the current available results of metabolomic biomarkers linked to gastrointestinal cancer, and discussed the altered metabolism pathways including carbohydrate metabolism, amino acid metabolism, lipids and nucleotide metabolism and other metabolisms. The authors believe that metabolomics will benefit deeper understandings of the pathogenic mechanism, discovery of biomarkers of the diseases and aid the search for drug targets as we move toward the era of personalized medicine. Personalized medication for tumors can improve the curative effect, avoid side effects and medical resource waste. As a promising and important research tool, metabolomics that targets the entire cancer-specific metabolites network should be applied more widely in cancer research.